Motilal Oswal
  • SENSEX
    NIFTY 50
Motilal Oswal
Market

Top stocks to watch out for on June 24: IndusInd Bank, BHEL, Glenmark Pharma, CG Power

Updated : 2019-06-24 07:38:13

Indian shares are likely to open little changed on Monday following muted trades in global markets and a spike in oil prices. Asian shares traded cautious as investors await US-China trade negotiations ahead of G20 meeting this weekend. Oil prices rose on worries over heightened tensions between the US and Iran. Indian benchmark indices on Friday ended over 1 percent lower on weak global cues. At 7.00 AM, the SGX Nifty futures traded at 1.50 points, or 0.01 percent, higher at 11,755.50, indicating a flat start to the Sensex and the Nifty 50. Here are the top stocks to watch out for in today's trade:

IndusInd Bank: The Hindujas will pump Rs 2,700 crore into Indusind Bank through a warrant issue to ramp up the promoter holding after the merger of Bharat Financial, reported PTI, citing a senior official from the private sector lender. (Image: Company)
IndusInd Bank: The Hindujas will pump Rs 2,700 crore into Indusind Bank through a warrant issue to ramp up the promoter holding after the merger of Bharat Financial, reported PTI, citing a senior official from the private sector lender. (Image: Company)
Glenmark Pharmaceuticals: The USFDA has issued a complete response letter (CRL) regarding the new drug application for Ryaltris. The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing facilities. The CRL does not specify any deficiencies with the clinical data supporting the New Drug Application for Ryaltris. (Image: Company)
Glenmark Pharmaceuticals: The USFDA has issued a complete response letter (CRL) regarding the new drug application for Ryaltris. The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing facilities. The CRL does not specify any deficiencies with the clinical data supporting the New Drug Application for Ryaltris. (Image: Company)
BHEL: The state-owned firm has won an order worth Rs 840 crore from an NTPC subsidiary for emission control equipment. (Image: Company)
BHEL: The state-owned firm has won an order worth Rs 840 crore from an NTPC subsidiary for emission control equipment. (Image: Company)
CG Power: The board has approved the sale of the remaining portion of the company’s land situated at Kanjurmarg to Evie Real Estate for an aggregate sum of Rs 498.96 crore.
CG Power: The board has approved the sale of the remaining portion of the company’s land situated at Kanjurmarg to Evie Real Estate for an aggregate sum of Rs 498.96 crore.
Star Cement: The board unanimously decided not to proceed with the scheme of amalgamation with WSO and withdraw the scheme. The board has also approved buyback of 68 lakh shares at Rs 150 per share for an aggregate amount of Rs 102 crore. Record date is July 5.
Star Cement: The board unanimously decided not to proceed with the scheme of amalgamation with WSO and withdraw the scheme. The board has also approved buyback of 68 lakh shares at Rs 150 per share for an aggregate amount of Rs 102 crore. Record date is July 5.
UPL: The company has set July 3 as a record date for bonus shares. (Image: Company)
UPL: The company has set July 3 as a record date for bonus shares. (Image: Company)
Neuland Labs: The USFDA inspected our Unit 1 manufacturing facility at Bonthapally, Hyderabad, and issued a Form 483 with five observations. (Image: Company)
Neuland Labs: The USFDA inspected our Unit 1 manufacturing facility at Bonthapally, Hyderabad, and issued a Form 483 with five observations. (Image: Company)
Tata Steel: It will seek shareholders' nod for the reappointment of T V Narendran as CEO and MD of the company. The company's next annual general meeting is scheduled for July 19 in Mumbai. (Image: Reuters)
Tata Steel: It will seek shareholders' nod for the reappointment of T V Narendran as CEO and MD of the company. The company's next annual general meeting is scheduled for July 19 in Mumbai. (Image: Reuters)
Sun Pharma: Sun Pharma: The firm clarified that the USFDA conducted a pre-approval inspection and issued a Form 483, with four observations. (Image: Reuters)
Sun Pharma: Sun Pharma: The firm clarified that the USFDA conducted a pre-approval inspection and issued a Form 483, with four observations. (Image: Reuters)
Dr Reddy’s Laboratories: The USFDA has completed inspection with 2 observation at Duvvada, Visakhapatnam. The firm has also announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the US market.
Dr Reddy’s Laboratories: The USFDA has completed inspection with 2 observation at Duvvada, Visakhapatnam. The firm has also announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the US market.
Bandhan Bank: The NCLT approves the merger of Gruh Finance with Bandhan Bank. (Image: Reuters)
Bandhan Bank: The NCLT approves the merger of Gruh Finance with Bandhan Bank. (Image: Reuters)
Live TV

Ask Our Experts CNBC TV18